Biography:
John Wahlich has worked as a consultant in the pharmaceutical sciences for over 5 years. Prior to this he had over 30 years’ experience in product development in the pharmaceutical industry. John is a chemist by training with a Ph.D. in the pharmaceutical sciences from Nottingham University School of Pharmacy, UK. He has analytical and formulation expertise gained from leadership roles in product line extensions, physical properties and early stage development in GlaxoSmithKline and other major pharmaceutical companies. He is a member of the UK Association of Pharmaceutical Sciences (APSGB) Executive. He currently works as a consultant for VHsquared, Cambridge, UK and for a number of other pharmaceutical organisations.
Title : Oral delivery of a novel antibody domain (Vorabody™) for the treatment of Crohn’s Disease